DJ Incyte Corp. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Incyte Corp. $(INCY)$ slid 2.17% to $123.28 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.58% to 7,591.70 and Dow Jones Industrial Average falling 0.60% to 52,064.10.
Incyte Corp. closed 7.03% below its 52-week high of $132.60, which the company reached on July 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ fell 4.07% to $247.51, Bio-Techne Corp. (TECH) fell 0.24% to $72.08, and BioMarin Pharmaceutical Inc. $(BMRN)$ rose 1.71% to $65.51.
Trading volume (1.5 M) remained 148,083 below its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.